[Pituitary Adenylate Cyclase Activating Polypeptide Ameliorates the Damage and Inhibits the Increase of Intracellular Calcium Concentration in Cultured Hippocampal Neurons Induced by Glutamate]
Overview
Affiliations
Hippocampal neurons cultured from 7 to 9 d in vitro were used to observe the effect of glutamate. Treatment of glutamate for 24 h greatly decreased neuronal survival and pretreatment with pituitary adenylate cyclase activating polypeptide (PACAP) significantly attenuated hippocampal neuron death induced by glutamate. Moreover, glutamate dose-dependently increased the intracellular calcium concentration in cultured hippocampal neurons, while PACAP inhibited the increase of intracellular calcium concentration induced by glutamate. PACAP 6-38, a specific PACAP type I receptor antagonist, completely inhibited the amelioration of glutamate induced death and the decrease of intracellular calcium concentration induced by PACAP in cultured hippocampal neurons. The data suggest that PACAP has a neuroprotective effect on the hippocampal neuronal damage induced by glutamate, which is related to an inhibition of glutamate-induced increase of intracellular calcium concentration and mediated by PACAP type I receptor.
Nemeth A, Szabadfi K, Fulop B, Reglodi D, Kiss P, Farkas J Neurotox Res. 2013; 25(1):57-67.
PMID: 24155155 DOI: 10.1007/s12640-013-9428-x.
Tamas A, Szabadfi K, Nemeth A, Fulop B, Kiss P, Atlasz T Neurotox Res. 2011; 21(4):435-44.
PMID: 22203609 DOI: 10.1007/s12640-011-9298-z.